Adora Ndu
CIK: 0001865210
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ACADIA PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
Exercise(M)Direct8.1K shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
Award(A)DirectRestricted Stock Units
9.3K shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
Award(A)DirectDirector Stock Options (Right to Buy)
16K shares- - May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
Award(A)DirectDirector Stock Options (Right to Buy)
13.8K shares- - May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
Exercise(M)Direct9.4K shares- - May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
Award(A)DirectRestricted Stock Units
8.1K shares- - Oct 12, 2024ACAD
ACADIA PHARMACEUTICALS INC
Exercise(M)Direct4.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Exercise(M) | 8,107 | - | $0 | Direct |
| May 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award(A) Restricted Stock Units | 9,311 | - | - | Direct |
| May 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award(A) Director Stock Options (Right to Buy) | 16,004 | - | - | Direct |
| May 29, 2025 | ACAD ACADIA PHARMACEUTICALS INC | Award(A) Director Stock Options (Right to Buy) | 13,793 | - | - | Direct |
| May 29, 2025 | ACAD ACADIA PHARMACEUTICALS INC | Exercise(M) | 9,387 | - | - | Direct |
| May 29, 2025 | ACAD ACADIA PHARMACEUTICALS INC | Award(A) Restricted Stock Units | 8,107 | - | - | Direct |
| Oct 12, 2024 | ACAD ACADIA PHARMACEUTICALS INC | Exercise(M) | 4,381 | - | $0 | Direct |
1-7 of 7 transactions
About Ndu Adora
Ndu Adora (SEC CIK 0001865210) files insider reports with the SEC as Director of ACADIA PHARMACEUTICALS INC (ACAD).
Signal8 holds 3 ownership filings by Ndu Adora, all Form 4s, filed between Oct 15, 2024 and Jun 1, 2026. Those filings report 7 transactions, from Oct 12, 2024 to May 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ndu Adora's filings is in SAN DIEGO, CA.
Recent filings by Ndu Adora
- May 29, 2026: Option exercise of ACAD shares (Form 4, code M).
- May 29, 2026: Grants or awards of ACAD derivative securities (2 lines, Form 4, code A).
- May 29, 2025: Grant or award of ACAD derivative securities (Form 4, code A).
- May 29, 2025: Option exercise of ACAD shares (Form 4, code M).
- May 29, 2025: Grant or award of ACAD derivative securities (Form 4, code A).
Other insiders filing for ACADIA PHARMACEUTICALS INC (ACAD)
- Schneyer Mark C., EVP, CHIEF FINANCIAL OFFICER
- Thompson Elizabeth H.Z., EVP, Head of Research & Dev
- Kihara James, PRINCIPAL ACCOUNTING OFFICER
- BAKER BROS. ADVISORS LP, Director
- HARRIGAN EDMUND, Director
- Brege Laura, Director